Clean Harbors' (CLH) Loss Narrows In Q1, Guidance Intact
Zacks Investment Research | May 03, 2018 02:35AM ET
Clean Harbors, Inc.’s (NYSE:CLH) first-quarter 2018 adjusted loss came in at 12 cents per share compared with a loss of 19 cents in the year-ago quarter. The figure was narrower than the Zacks Consensus Estimate of a loss of 14 cents.
Revenues came in at $749.8 million, surpassing the consensus mark of $717.8 million and increasing 8.8% year over year on growth across key verticals.
During the earnings call, management stated that the integration of Veolia's U.S. industrial business that was acquired in the fourth quarter is in progress. The acquisition is expected to provide significant scale and industrial services capabilities while doubling the size of the existing U.S. Industrial Services business.
The acquired business’s operational footprint, particularly the strong presence in the Midwest, will complement Clean Harbors’ existing network of locations. Addition of this business will create new cross-selling opportunities and drive incremental volumes into waste disposal network.
Notably, shares of Clean Harbors have declined 17.8% in the past year against the 11% gain of its industry .
Let’s take a closer look at the numbers.
Segmental Revenues
Starting this year, the company has formed a regional sales and service organization and created the Environmental Services segment. The new segment includes Technical Services, Industrial and Field Services, and Oil, Gas and Lodging segments.
Environmental Services accounted for 63% of total revenues in the reported quarter and improved 10.2% year over year to $472.4 million. Growth was driven by strength in Industrial Services lines of business, Veolia acquisition, higher volumes in the company’s disposal network, strong base business and project work. The segment benefited from the improving industrial economy that boosted key industry verticals like chemical, manufacturing, and energy.
Safety-Kleen revenues increased to $278 million from $260.8 million in the prior-year quarter. The growth was buoyed by higher base oil and blended pricing and strength in the company’s branch network.
Clean Harbors, Inc. Revenue (TTM)
Profitability Performance
Adjusted EBITDA of $88.3 million increased 10% year over year. Adjusted EBITDA margin increased 22 basis points (bps) year over year to 22.3%.
Get The News You Want
By segments, Environmental Services’ adjusted EBITDA was $61.4 million, up 2% year over year. Safety-Kleen’s adjusted EBITDA of $61.8 million showed an improvement of 18.2% year over year.
Balance Sheet, Cash Flow, Share Repurchase
Clean Harbors exited the quarter with cash and cash equivalents of $186.4 million, down from $319.4 million in the fourth quarter of 2017. Inventories and supplies were $181.4 million, up from $176 million in the prior quarter. The company had long-term debt of $1.6 billion at the end of the quarter.
Cash flow from operating activities was $51.9 million compared with $57.1 million in the prior quarter. Adjusted free cash flow totaled $8.5 million versus $15.7 million in the preceding quarter.
During the first quarter, the company repurchased approximately 280,000 shares for $14.3 million.
2018 Guidance
Clean Harbors reiterated its 2018 guidance. It expects adjusted EBITDA in the range of $440−$480 million. Veolia U.S. industrial business is expected to add $8-$10 million to adjusted EBITDA.
Net cash from operating activities is projected between $295 million and $345 million. Adjusted free cash flow is expected in the range of $125 million to $155 million.
Zacks Rank & Upcoming Releases
Clean Harbors has a Zacks Rank #2 (Buy). You can see .
Investors interested in the broader Business Services sector are keenly awaiting earnings reports from key players like Gartner, Inc. (NYSE:IT) , The Dun & Bradstreet Corp. (NYSE:DNB) and Broadridge Financial Solutions Inc. (NYSE:BR) . While Garter and Dun & Bradstreet will release first-quarter 2018 results on May 8 and May 9, respectively, Broadridge will report third-quarter fiscal 2018 numbers on May 8.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Zacks Investment Research
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.